Alphabet, WuXi AppTec, Celgene, Roche and Novartis are in line to exit precision oncology therapy developer Ideaya Biosciences, which has filed to go public.

Goldman Sachs led a round for the construction lending platform that included Canapi and Regions Bank, boosting its overall funding to $55m.

Cirtemo, which incorporated University of South Carolina-born MagAssemble, has been acquired by Thorlabs for an unspecified amount.

Edtech provider Renaissance has bought UM's early years education assessment provider Early Learning Labs, vindicating twenty years of government-funded research.

The We Company, valued at $47bn as of January, confidentially filed for an IPO in December that would provide exits for SoftBank and Jin Jiang International.

The drug developer has confidentially filed for an IPO having collected $124m in funding from investors including PureTech Health, Nan Fung and Alexandria Real Estate Equities.

The 3D design modelling platform has increased its overall funding to $87m with a series C round that included Alphabet unit GV and Standard Industries.

Amgen is among the seed investors for Stanford-licensed drug release technology developer Navan Technologies, which hopes its nanoinjection technique will enable more cell and gene therapies to be produced at scale.

Allied Minds will focus on funding existing companies after exiting the red to bank a $47.3m net profit for 2018.

Chris Downing will stand aside as vice-president and director of Georgia Tech’s Enterprise Innovation Institute, drawing the curtain on more than three decades at Georgia Tech.